Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 14 studies | 35% ± 15% | |
| fibroblast | 10 studies | 26% ± 11% | |
| macrophage | 9 studies | 23% ± 8% | |
| smooth muscle cell | 6 studies | 24% ± 4% | |
| B cell | 5 studies | 30% ± 11% | |
| myeloid cell | 5 studies | 26% ± 10% | |
| ciliated cell | 5 studies | 25% ± 4% | |
| pericyte | 5 studies | 25% ± 4% | |
| mast cell | 4 studies | 20% ± 2% | |
| retinal ganglion cell | 4 studies | 38% ± 18% | |
| epithelial cell | 4 studies | 29% ± 8% | |
| adipocyte | 4 studies | 33% ± 21% | |
| oligodendrocyte precursor cell | 4 studies | 23% ± 4% | |
| alveolar macrophage | 3 studies | 22% ± 3% | |
| naive B cell | 3 studies | 17% ± 2% | |
| basal cell | 3 studies | 25% ± 11% | |
| neuron | 3 studies | 26% ± 6% | |
| astrocyte | 3 studies | 31% ± 2% | |
| glutamatergic neuron | 3 studies | 25% ± 11% | |
| abnormal cell | 3 studies | 19% ± 1% | |
| leukocyte | 3 studies | 20% ± 3% | |
| endothelial cell | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| kidney | 100% | 4870.07 | 89 / 89 | 100% | 224.41 | 901 / 901 |
| ovary | 100% | 5102.43 | 180 / 180 | 100% | 173.81 | 430 / 430 |
| thymus | 100% | 5909.36 | 653 / 653 | 100% | 136.66 | 605 / 605 |
| skin | 100% | 4442.43 | 1806 / 1809 | 100% | 260.83 | 472 / 472 |
| uterus | 100% | 5901.91 | 170 / 170 | 100% | 131.52 | 458 / 459 |
| prostate | 100% | 6140.35 | 245 / 245 | 99% | 136.50 | 499 / 502 |
| brain | 99% | 4700.14 | 2623 / 2642 | 100% | 177.54 | 705 / 705 |
| adrenal gland | 100% | 4912.66 | 258 / 258 | 99% | 179.32 | 228 / 230 |
| lung | 100% | 5396.90 | 576 / 578 | 99% | 123.93 | 1145 / 1155 |
| breast | 100% | 9231.94 | 459 / 459 | 99% | 132.26 | 1103 / 1118 |
| pancreas | 100% | 3161.87 | 327 / 328 | 99% | 161.59 | 176 / 178 |
| esophagus | 99% | 5728.77 | 1432 / 1445 | 99% | 86.39 | 181 / 183 |
| bladder | 100% | 7305.48 | 21 / 21 | 97% | 106.93 | 490 / 504 |
| intestine | 99% | 6275.32 | 958 / 966 | 97% | 85.48 | 512 / 527 |
| stomach | 100% | 4468.17 | 359 / 359 | 96% | 93.21 | 275 / 286 |
| liver | 60% | 1093.80 | 136 / 226 | 69% | 70.99 | 281 / 406 |
| adipose | 100% | 12512.55 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 9437.45 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 419.30 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 176.53 | 29 / 29 |
| spleen | 100% | 3839.88 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 109.87 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 194.13 | 1 / 1 |
| heart | 100% | 9236.48 | 860 / 861 | 0% | 0 | 0 / 0 |
| muscle | 99% | 4363.04 | 797 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 45% | 1328.32 | 414 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0051781 | Biological process | positive regulation of cell division |
| GO_0060754 | Biological process | positive regulation of mast cell chemotaxis |
| GO_0045766 | Biological process | positive regulation of angiogenesis |
| GO_0050918 | Biological process | positive chemotaxis |
| GO_0060976 | Biological process | coronary vasculature development |
| GO_0001934 | Biological process | positive regulation of protein phosphorylation |
| GO_0060048 | Biological process | cardiac muscle contraction |
| GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
| GO_0002040 | Biological process | sprouting angiogenesis |
| GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
| GO_0001666 | Biological process | response to hypoxia |
| GO_0006493 | Biological process | protein O-linked glycosylation |
| GO_0048010 | Biological process | vascular endothelial growth factor receptor signaling pathway |
| GO_0050930 | Biological process | induction of positive chemotaxis |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005576 | Cellular component | extracellular region |
| GO_0016020 | Cellular component | membrane |
| GO_0031093 | Cellular component | platelet alpha granule lumen |
| GO_0008201 | Molecular function | heparin binding |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0008083 | Molecular function | growth factor activity |
| GO_0042056 | Molecular function | chemoattractant activity |
| GO_0005172 | Molecular function | vascular endothelial growth factor receptor binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | VEGFB |
| Protein name | Vascular endothelial growth factor B Vascular endothelial growth factor B (VEGF-B) (VEGF-related factor) (VRF) Vascular endothelial growth factor B isoform VEGF-B167 |
| Synonyms | VRF |
| Description | FUNCTION: Growth factor for endothelial cells. VEGF-B167 binds heparin and neuropilin-1 whereas the binding to neuropilin-1 of VEGF-B186 is regulated by proteolysis. |
| Accessions | ENST00000541681.1 ENST00000309422.7 [P49765-1] H0YGB6 Q7LAP4 ENST00000426086.3 [P49765-2] P49765 Q8TEV2 |